The DNA chip segment is expected to register a high revenue growth rate over the forecast period. This can be attributed to high usage of DNA chips in genomics research, molecular biology, and ...
The Geniom® RT Analyzer, a new benchtop microarray processing instrument, was presented by febit at Select Bioscience’s “Advances in Microarray Technology”. The platform complements Geniom® One, the ...
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report is an ...
According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...
Stephen Quake, a bioengineer and applied physicist at Stanford University, has always been interested in the interface between physics and biology. During his work at the California Institute of ...
Biochips are a class of technology that can perform simultaneous biochemical reactions. They can be classified as DNA chips, protein chips, lab-on-a-chips, and tissue and cell arrays on the basis of ...
febit has announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA. This method forms the basis of a novel technology that enables the ...